Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$472,928
+$13,412 QoQ
Shares Held
1,306
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2,225
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WHALEROCK POINT PARTNERS, LLC holds $17,592,227 across 8 Drug Manufacturers - General names. AMGN ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
30,416 | $7,724,751 | |
| 2 | LLY |
ELI LILLY & Co
|
2,589 | $3,105,324 | |
| 3 | ABBV |
AbbVie Inc.
|
10,057 | $2,530,743 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,615 | $2,263,527 | |
| 5 | PFE |
Pfizer Inc
|
35,762 | $861,148 | |
| 6 | AMGN |
Amgen Inc
This page
|
1,306 | $472,928 | |
| 7 | NVS |
Novartis AG
|
2,050 | $321,276 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
5,424 | $312,530 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $472,928 | 1,306 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $459,516 | 1,306 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $427,466 | 1,306 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $396,773 | 1,406 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $405,412 | 1,452 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $452,370 | 1,452 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $509,551 | 1,955 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $659,563 | 2,047 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $639,585 | 2,047 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $582,003 | 2,047 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $618,378 | 2,147 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $630,779 | 2,347 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $521,080 | 2,347 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $550,464 | 2,277 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $598,031 | 2,277 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $502,867 | 2,231 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $542,802 | 2,231 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $660,410 | 2,731 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $614,393 | 2,731 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $661,554 | 3,111 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $770,493 | 3,161 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $786,488 | 3,161 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $726,777 | 3,161 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $204,090 | 803 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $753,100 | 3,193 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $722,326 | 3,563 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||